Metropolis Healthcare Ltd
Metropolis Healthcare Q2 Results 2026 (FY27) investor presentation: Revenue & Margins
Q2 FY27 investor presentation: what the company reported on revenue, margins and capex.
Guidance rank: #22 of 32 in Healthcare Services
See the sector's top 10 — free with your mobile number.
Metropolis Healthcare Ltd Q2 FY27 key numbers
- Revenue
- Q2FY27 revenue from operations: INR 496.8 Cr, up 15.8% YoY.
As stated in Metropolis Healthcare Ltd's Q2 FY27 investor presentation · published 3 Nov 2026. Reported figures, not investment advice.
Based on Metropolis Healthcare Ltd's Q2 FY27 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the investor presentation reports, not management guidance.
The short version
Q2FY27 revenue from operations: INR 496.8 Cr, up 15.8% YoY (Page 11). Q2 FY27 EBITDA: ₹134.9 Cr, up 23.9% YoY.
From Metropolis Healthcare Ltd's Q2 FY27 earnings-call transcript · updated 3 Nov 2026.
How did Metropolis Healthcare's revenue grow in the September 2026 quarter?
- Q2FY27 revenue from operations: INR 496.8 Cr, up 15.8% YoY (Page 11)
- Q2FY27 total revenue: INR 497 Cr, 16% YoY growth (Page 5)
- B2C revenue: INR 289 Cr, 17% YoY growth (Page 6)
- B2B revenue: INR 208 Cr, 15% YoY growth (Page 6)
- Patient volume: 4.07 million, up 10% YoY (Page 6)
- Test volume: 8.68 million, up 11% YoY (Page 6)
2 more points from Metropolis Healthcare Ltd's call on revenue
Create a free account to keep reading this call
What happened to Metropolis Healthcare's margins in Q2 FY27?
See what Metropolis Healthcare Ltd said on profitability & margins — free account, 30 seconds.
What capex is Metropolis Healthcare planning?
Top-ranked in Healthcare Services
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Is Metropolis Healthcare raising money or cutting debt?
See what Metropolis Healthcare Ltd said on fundraising & capital structure — free account, 30 seconds.
How big is Metropolis Healthcare's order book?
See what Metropolis Healthcare Ltd said on order book & pipeline — free account, 30 seconds.
Metropolis Healthcare Ltd — Quarterly revenue & net profit
Q2 FY27 figures are not in this chart yet. Latest shown: Jun 2026 (Q1 FY27). The Q2 FY27 numbers from the filing are in the analysis on this page.
Reported quarterly figures (₹ Cr). Latest (Q1 FY27): revenue ₹450 Cr, net profit ₹57 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Metropolis Healt's management said in earlier quarters
- Q2 FY26 earnings call analysis →
- Q1 FY27 earnings call analysis →
- Q1 FY27 earnings call analysis →
- Q3 FY26 earnings call analysis →
- Q1 FY26 earnings call →
- Q4 FY25 earnings call →
- Q3 FY25 earnings call →
- Q2 FY25 earnings call →
- Q2 FY25 earnings call →
- Q1 FY25 earnings call →
- Q4 FY24 earnings call →
- Q3 FY24 earnings call →
Others in Healthcare Services this season
- Vijaya Diagnostic Centre (Q2 FY27)
Q2 FY27 Revenue from Operations: INR 2,554 Mn, up 26.7% YoY (Page 10, 9) . Key investor presentation takeaways from Vijaya Diagnostic Centre Ltd's Q2 FY27 inves
- Shalby (Q2 FY27)
Consolidated Total Revenue for Q2 FY27: ₹3,182 million vs ₹2,899 million in Q2 FY26, up 9.8% YoY (Pages 5, 6, 8, 9) . Key investor presentation takeaways from S
- Nephrocare Health Services (Q2 FY27)
Q2 FY27 Revenue from Operations: ₹303.4 Cr, up 23.5% YoY from ₹245.7 Cr in Q2 FY26 (Page 9). Key investor presentation takeaways from Nephrocare Health Services
- Global Health Ltd (Q2 FY27)
Q2 FY2027 revenue from operations: INR 14,690 million, up 33.6% year-on-year (YoY). Key investor presentation takeaways from Global Health Ltd's Q2 FY27 investo
Potential multibaggers · Q2 FY27
Potential multibaggers in Healthcare Services
on management's own guidance
- Strong growth2
- Strong growth1
- Aster DM Quality Care LtdGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Metropolis Healthcare Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Metropolis Healthcare Ltd Q2 FY27 results?
Q2FY27 revenue from operations: INR 496.8 Cr, up 15.8% YoY (Page 11). Q2 FY27 EBITDA: ₹134.9 Cr, up 23.9% YoY.
What is Metropolis Healthcare Ltd share price analysis?
Metropolis Healthcare Ltd currently shows a neutral. The stock trades at a P/E of 56.7 with a market cap of ₹11,798 Cr. Investors should review the full earnings analysis for detailed insights.
Keep Metropolis Healthcare Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.